908 Devices Inc. (MASS)
NASDAQ:MASS
Want to see MASS full AI Analyst Report?
MASS Stock Chart & Stats
$6.20
-$0.07(-3.29%)
At close: 4:00 PM EST
$6.20
-$0.07(-3.29%)
Day’s Range― - ―
52-Week Range$5.03 - $9.34
Previous CloseN/A
Volume74.64K
Average Volume (3M)289.68K
Market Cap
$302.89M
Enterprise Value$254.92M
Total Cash (Recent Filing)$111.74M
Total Debt (Recent Filing)$4.47M
Price to Earnings (P/E)―
Beta1.07
Next Earnings
Aug 11, 2026EPS Estimate
-0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.98
Shares Outstanding37,813,620
10 Day Avg. Volume325,346
30 Day Avg. Volume289,683
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.32
Price to Sales (P/S)3.38
P/FCF Ratio-7.72
Enterprise Value/Market Cap0.84
Enterprise Value/Revenue4.41
Enterprise Value/Gross Profit9.00
Enterprise Value/Ebitda-13.25
Forecast
1Y Price Target
$10.00Price Target Upside61.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.41
Revenue Forecast (FY)$65.94M
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthA large cash balance with no debt gives management durable optionality to fund product development, commercialization, and integration of acquisitions without near-term refinancing. This reduces solvency risk while the business scales toward consistent profitability and recurring revenue growth.
Installed Base Expansion & Device TractionGrowing device placements and an expanding installed base create a durable platform for follow-on consumables, service contracts, and software attach. Recurring aftermarket demand from an installed base supports revenue visibility and margin leverage as unit volumes scale over months to years.
Accretive M&A To Deepen Recurring RevenueAcquiring a subscription-heavy business with high retention broadens recurring revenue and international reach, accelerating predictable revenue mix. Combined with demonstrated M&A success (RedWave), this supports a structural shift toward higher recurring sales and long-term margin stability if integration succeeds.
Bears Say
Persistent Negative Cash FlowConsistent negative operating and free cash flow mean the business is still burning cash despite revenue growth. Over months this increases reliance on existing liquidity or external financing, constraining reinvestment and raising dilution or cost-cutting risk if adjusted EBITDA improvements stall.
Declining Recurring Revenue MixA falling recurring mix undermines revenue predictability and weakens the long-term margin profile that consumables and service attach rates provide. If aftermarket/service monetization lags installed base growth, the company may struggle to convert placements into stable, high-margin recurring cash flows.
Near-term Integration & Profitability HeadwindAcquisition integration will require investment and may depress near-term margins and adjusted EBITDA. Execution risk in scaling NIRLAB in the U.S. and contingent consideration revaluations can create earnings volatility and delay the expected accretion to recurring revenue and profitability.
908 Devices News
MASS FAQ
What was 908 Devices Inc.’s price range in the past 12 months?
908 Devices Inc. lowest stock price was $5.03 and its highest was $9.34 in the past 12 months.
What is 908 Devices Inc.’s market cap?
908 Devices Inc.’s market cap is $302.89M.
When is 908 Devices Inc.’s upcoming earnings report date?
908 Devices Inc.’s upcoming earnings report date is Aug 11, 2026 which is in 61 days.
How were 908 Devices Inc.’s earnings last quarter?
908 Devices Inc. released its earnings results on May 06, 2026. The company reported -$0.082 earnings per share for the quarter, beating the consensus estimate of -$0.14 by $0.058.
Is 908 Devices Inc. overvalued?
According to Wall Street analysts 908 Devices Inc.’s price is currently Undervalued.
Does 908 Devices Inc. pay dividends?
908 Devices Inc. does not currently pay dividends.
What is 908 Devices Inc.’s EPS estimate?
908 Devices Inc.’s EPS estimate is -0.15.
How many shares outstanding does 908 Devices Inc. have?
908 Devices Inc. has 37,813,620 shares outstanding.
What happened to 908 Devices Inc.’s price movement after its last earnings report?
908 Devices Inc. reported an EPS of -$0.082 in its last earnings report, beating expectations of -$0.14. Following the earnings report the stock price went up 13.681%.
Which hedge fund is a major shareholder of 908 Devices Inc.?
Currently, no hedge funds are holding shares in MASS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
908 Devices Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$10.00 (61.29% Upside)
$10.00 (61.29% Upside)
Blogger Sentiment
Bullish
MASS Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 132.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.4%
Last 30 Days ▲ 6.5%
Last 30 Days ▲ 6.5%
News Sentiment
Very Bearish
Bullish news 19%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
14.46%
12-Months-Change
Fundamentals
Return on Equity
-25.50%
Trailing 12-Months
Asset Growth
-4.76%
Trailing 12-Months
Company Description
908 Devices Inc.
908 Devices Inc. is an established technology company providing advanced mass spectrometry (Mass Spec) solutions. They develop specialized portable and benchtop instruments designed to analyze and identify unknown or hidden substances across various fields. Their products address needs in life sciences research, biopharmaceutical manufacturing, industrial biotechnology, forensic investigations, and related sectors. Key offerings include: The MX908, a handheld, battery-operated Mass Spec device capable of rapid on-site detection and identification of unknown gaseous, liquid, and solid materials. The Rebel, a compact desktop analyzer that delivers real-time data concerning the extracellular environment within bioprocesses. The ZipChip solution, a high-resolution, user-friendly separation platform engineered to optimize the preparation and analysis of samples for Mass Spec. With operations spanning the globe, 908 Devices Inc. serves markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was established in 2012 and is based in Boston, Massachusetts.
MASS Company Deck
MASS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveys a predominantly positive operational and strategic trajectory: revenue and handheld product growth, improved margins, reduced adjusted EBITDA loss, strong cash position, and the strategic acquisition of NIRLAB that accelerates recurring revenue and expands addressable markets. Key near-term negatives include a wider GAAP net loss driven by a noncash contingent consideration revaluation, a decline in recurring revenue this quarter driven by service reductions, and a modest near-term EBITDA drag from NIRLAB as it is integrated and scaled in the U.S. On balance, the highlights (revenue growth, margin expansion, device momentum, strengthened guidance, cash balance, and accretive M&A strategy) significantly outweigh the lowlights, which are largely one-time accounting charges or manageable integration risks.View all MASS earnings summariesMASS Stock 12 Month Forecast
Average Price Target
$10.00
▲(61.29% Upside)
Technical Analysis
Senseonics Holdings
―
Quanterix
―
Nano-X Imaging
―
TriSalus Life Sciences
―
Cytek Biosciences
―
Ownership Overview
37.15% Insiders
10.61% Mutual Funds
16.10% Other Institutional Investors
23.88% Public Companies and
Individual Investors